Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia
- 2 June 2010
- journal article
- Published by Elsevier BV in Brain Research
- Vol. 1334, 84-92
- https://doi.org/10.1016/j.brainres.2010.04.006
Abstract
No abstract availableKeywords
Funding Information
- Japanese Ministry of Education, Culture, Sports, Science and Technology (20390388)
- National Multiple Sclerosis Society (USA) (RG2135; CA1009A10)
- National Institutes of Health (NS43432)
- Medical and Rehabilitation and Development Research Services of the Department of Veterans Affairs
- Bumpus Foundation
This publication has 33 references indexed in Scilit:
- Homing and engraftment of progenitor cells: A prerequisite for cell therapyJournal of Molecular and Cellular Cardiology, 2008
- Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult ratsBrain Research, 2008
- Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in ratsLife Sciences, 2008
- Therapeutic Benefits by Human Mesenchymal Stem Cells (hMSCs) and Ang-1 Gene-Modified hMSCs after Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2007
- Mesenchymal Stem Cells Derived from Peripheral Blood Protects against IschemiaJournal of Neurotrauma, 2007
- Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cellsBrain Research, 2006
- Intravenous administration of glial cell line‐derived neurotrophic factor gene‐modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult ratJournal of Neuroscience Research, 2006
- Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemiaBrain, 2006
- Role of angiogenesis in patients with cerebral ischemic stroke.Stroke, 1994
- Brain edema and cerebrovascular permeability during cerebral ischemia in rats.Stroke, 1990